144 related articles for article (PubMed ID: 10975551)
1. Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy.
Little RF; Yarchoan R; Wilson WH
Curr Opin Oncol; 2000 Sep; 12(5):438-44. PubMed ID: 10975551
[TBL] [Abstract][Full Text] [Related]
2. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
3. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors.
Miralles P; Berenguer J; Ribera JM; Rubio R; Mahillo B; Téllez MJ; Lacruz J; Valencia E; Santos J; Rodríguez-Arrondo F; Pintado V;
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):167-73. PubMed ID: 17117144
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
Ratner L; Lee J; Tang S; Redden D; Hamzeh F; Herndier B; Scadden D; Kaplan L; Ambinder R; Levine A; Harrington W; Grochow L; Flexner C; Tan B; Straus D;
J Clin Oncol; 2001 Apr; 19(8):2171-8. PubMed ID: 11304769
[TBL] [Abstract][Full Text] [Related]
6. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
Re A; Cattaneo C; Michieli M; Casari S; Spina M; Rupolo M; Allione B; Nosari A; Schiantarelli C; Vigano M; Izzi I; Ferremi P; Lanfranchi A; Mazzuccato M; Carosi G; Tirelli U; Rossi G
J Clin Oncol; 2003 Dec; 21(23):4423-7. PubMed ID: 14581441
[TBL] [Abstract][Full Text] [Related]
7. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy.
Tirelli U; Spina M; Gaidano G; Vaccher E; Franceschi S; Carbone A
AIDS; 2000 Aug; 14(12):1675-88. PubMed ID: 10985303
[No Abstract] [Full Text] [Related]
9. Current status of the treatment of HIV-associated lymphoma.
Kaplan LD
Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156
[No Abstract] [Full Text] [Related]
10. Peripheral T-cell lymphoma in HIV-infected patients: a study of 17 cases in the combination antiretroviral therapy era.
Gilardin L; Copie-Bergman C; Galicier L; Meignin V; Brière J; Timsit JF; Bouchaud O; Gaulard P; Oksenhendler E; Gérard L
Br J Haematol; 2013 Jun; 161(6):843-51. PubMed ID: 23593987
[TBL] [Abstract][Full Text] [Related]
11. Advances in the management of HIV-related non-Hodgkin lymphoma.
Behler CM; Kaplan LD
Curr Opin Oncol; 2006 Sep; 18(5):437-43. PubMed ID: 16894290
[TBL] [Abstract][Full Text] [Related]
12. High-dose therapy and autologous stem cell transplantation for children with HIV-associated non-Hodgkin lymphoma.
Fluri S; Ammann R; Lüthy AR; Hirt A; Aebi C; Duppenthaler A; Leibundgut K
Pediatr Blood Cancer; 2007 Dec; 49(7):984-7. PubMed ID: 16685736
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus associated lymphoma.
Sparano JA
Curr Opin Oncol; 2003 Sep; 15(5):372-8. PubMed ID: 12960519
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Straus DJ
Recent Results Cancer Res; 2002; 159():143-8. PubMed ID: 11785838
[TBL] [Abstract][Full Text] [Related]
15. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects.
Levine AM
Semin Oncol; 2000 Aug; 27(4):442-53. PubMed ID: 10950371
[TBL] [Abstract][Full Text] [Related]
16. AIDS-related systemic non-Hodgkin's lymphoma at a large community program.
Vilchez RA; Kozinetz CA; Jorgensen JL; Kroll MH; Butel JS
AIDS Res Hum Retroviruses; 2002 Mar; 18(4):237-42. PubMed ID: 11860669
[TBL] [Abstract][Full Text] [Related]
17. Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Hentrich M; Hoffmann C; Mosthaf F; Müller M; Siehl J; Wyen C; Hensel M; ;
Ann Hematol; 2014 Jun; 93(6):913-21. PubMed ID: 24807241
[TBL] [Abstract][Full Text] [Related]
18. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V
Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471
[TBL] [Abstract][Full Text] [Related]
19. Improved outcome of AIDS-related lymphoma in patients with virologic response to highly active antiretroviral therapy.
Navarro JT; Ribera JM; Oriol A; Tural C; Millá F; Feliu E
J Acquir Immune Defic Syndr; 2003 Mar; 32(3):347-8. PubMed ID: 12626898
[No Abstract] [Full Text] [Related]
20. New controversies and new directions.
Ambinder RF
Curr Opin Oncol; 2000 Sep; 12(5):435-7. PubMed ID: 10975550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
